Home LiteratureArticle Details
PMID: 14986673 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S. Review

The immunological aspects of latency in tuberculosis.

Clinical immunology (Orlando, Fla.) ·Vol. 110 ·No. 1 ·2004-01-00 ·Pages 2-12

Chan J, Flynn J

Abstract

A unique feature of Mycobacterium tuberculosis is its ability to exist in the granuloma of an asymptomatic host in a latent state that can subsequently reactivate to cause active disease. The latent state of infection poses a major obstacle to eradicating tuberculosis. In latent tuberculosis, the host immune response is capable of controlling the infection and yet falls short of eradicating the pathogen. That the host immune response contributes to the maintenance of latent tuberculous infection is supported by the observation that certain immunodeficient states, including those associated with the human immunodeficiency virus and tumor necrosis factor neutralization therapy, are associated with increased risks for developing reactivation disease. Latent tuberculosis is the product of a complex set of interactions between M. tuberculosis and the host immune response. The molecular basis for the persistence phenotype of M. Tuberculosis and the pertinent host immune mechanisms that contribute to the maintenance of tuberculous latency are just beginning to be understood. This review discusses the interactions between M. tuberculosis and the macrophage, the primary host cell that the tubercle bacillus parasitizes.

MeSH Terms
Antigen Presentation/immunology,physiology Female Humans Male Middle Aged Mycobacterium tuberculosis/immunology Nitric Oxide/metabolism Phagosomes/metabolism Reactive Nitrogen Species/metabolism Tuberculosis, Pulmonary/immunology
Chemicals
Reactive Nitrogen Species Nitric Oxide
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Chan John
Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA. jchan@aecom.yu.edu
Flynn JoAnne
Article Info
Journal
Clinical immunology (Orlando, Fla.)
Abbr.
Clin Immunol
ISSN
1521-6616
Published
2004-01-00
Pages
2-12
Language
English
Region
United States
NLM ID
100883537
Subset
IM
Grants
NIAID NIH HHS · AI50732 · United States
NHLBI NIH HHS · HL71241 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com